Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013

Emerg Infect Dis. 2016 Mar;22(3):515-7. doi: 10.3201/eid2203.151049.

Abstract

As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin-peginterferon-α therapy.

Keywords: Abu Dhabi; MERS-CoV; Middle East respiratory syndrome coronavirus; UAE; United Arab Emirates; WHO; World Health Organization; fatal outcome; influenza-like illness; pregnancy; surveillance; treatment; viruses.

Publication types

  • Case Reports
  • Historical Article

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / history
  • Coronavirus Infections / virology*
  • Drug Therapy, Combination
  • Fatal Outcome
  • Female
  • History, 21st Century
  • Humans
  • Middle East Respiratory Syndrome Coronavirus* / classification
  • Middle East Respiratory Syndrome Coronavirus* / genetics
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Complications, Infectious / history
  • Pregnancy Complications, Infectious / virology*
  • United Arab Emirates / epidemiology

Substances

  • Antiviral Agents